127 related articles for article (PubMed ID: 11507290)
21. A simple method for determining split renal function from dynamic (99m)Tc-MAG3 scintigraphic data.
Wesolowski MJ; Conrad GR; Šámal M; Watson G; Wanasundara SN; Babyn P; Wesolowski CA
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):550-8. PubMed ID: 26537286
[TBL] [Abstract][Full Text] [Related]
22. Prolonged renal parenchymal retention of 99mTc mercaptoacetyltriglycine after nephron-sparing surgery.
Inoue Y; Kurimoto S; Kameyama S; Ohta N; Akahane M; Yoshikawa K; Yokoyama I; Minami M; Ohtomo K; Kitamura T
Nucl Med Commun; 2004 May; 25(5):509-13. PubMed ID: 15100511
[TBL] [Abstract][Full Text] [Related]
23. Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate.
Russell CD; Dubovsky EV
J Nucl Med; 1999 Jul; 40(7):1122-4. PubMed ID: 10405130
[TBL] [Abstract][Full Text] [Related]
24. Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance.
Hamscho N; Wilhelm A; Döbert N; Menzel C; Gossmann J; Berner U; Zaplatnikov K; Scheuermann EH; Grünwald F
Nuklearmedizin; 2005; 44(5):200-4. PubMed ID: 16395496
[TBL] [Abstract][Full Text] [Related]
25. Administered activity optimization in 99mTc-MAG3 renography for adults.
Díaz MP; Aparicio EE; Rizo OD; Díaz RR; Rodríguez CH
J Nucl Med Technol; 2003 Dec; 31(4):216-21. PubMed ID: 14657288
[TBL] [Abstract][Full Text] [Related]
26. Kidney function after nephrectomy for renal cell carcinoma.
Shirasaki Y; Tsushima T; Saika T; Nasu Y; Kumon H
Urology; 2004 Jul; 64(1):43-7; discussion 48. PubMed ID: 15245931
[TBL] [Abstract][Full Text] [Related]
27. Recovery of renal retention function by differentiating the Patlak-Rutland plot.
Kuyvenhoven JD; Ham HR; Piepsz A
Nucl Med Commun; 2004 May; 25(5):501-7. PubMed ID: 15100510
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases.
Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Koyanagi T; Furudate M; Torizuka K
Clin Nucl Med; 1993 May; 18(5):387-93. PubMed ID: 8508572
[TBL] [Abstract][Full Text] [Related]
29. Exercise acutely increases renal transit time of Tc-99m mercaptoacetyltriglycine (MAG3) in a post-liver transplant patient.
Murthy R; Chahal M; Appel G; Bergmann S; Tikofsky R; Fawwaz R; Van Heertum R
Clin Nucl Med; 2006 Dec; 31(12):829-34. PubMed ID: 17117088
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders.
Müller-Suur R; Bois-Svensson I; Mesko L
J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371
[TBL] [Abstract][Full Text] [Related]
31. Effect of arteriovenous difference in measuring renal function by single-injection plasma clearance: role of bolus.
Russell CD; Dubovsky EV
Nucl Med Biol; 1999 Aug; 26(6):699-705. PubMed ID: 10587110
[TBL] [Abstract][Full Text] [Related]
32. A theoretical four-compartment model to evaluate separate kidney technetium-99m-MAG3 kinetics in humans.
Curti G; DeMartini D; Santaniello B; Taddei G; Fresco GF
Kidney Int; 1998 Dec; 54(6):2029-36. PubMed ID: 9853268
[TBL] [Abstract][Full Text] [Related]
33. [Calculation of renal clearance by dynamic measurement of excreted activity].
Hackstein N; Bauer R
Nuklearmedizin; 1999; 38(2):43-8. PubMed ID: 10100230
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of renal function from 99mTc-MAG3 renography without blood sampling.
Inoue Y; Ohtake T; Yokoyama I; Yoshikawa K; Asai S; Ohtomo K
J Nucl Med; 1999 May; 40(5):793-8. PubMed ID: 10319752
[TBL] [Abstract][Full Text] [Related]
35. Technetium-99m mercaptoacetyltriglycine clearance values in children with minimal renal disease: can a normal range be determined?
Meyer G; Piepsz A; Kolinska J; Lepej J; Sixt R; Hahn K
Eur J Nucl Med; 1998 Jul; 25(7):760-5. PubMed ID: 9662599
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction.
Aktaş A; Aras M; Colak T; Gençoğlu A; Karakayali H
Transplant Proc; 2006 Mar; 38(2):449-53. PubMed ID: 16549144
[TBL] [Abstract][Full Text] [Related]
37. Formulation of lyophilized single vial kit of N-N-Ethylene-L-Dicysteine (EC) for labeling with
Afshan A; Sohaib M; Jehangir M
Pak J Pharm Sci; 2017 Jul; 30(4):1289-1295. PubMed ID: 29039327
[TBL] [Abstract][Full Text] [Related]
38. Radiopharmacokinetics, renal clearance and dosimetry of 99mTc-MAG3.
Arteaga de Murphy C; Molina-Trinidad E; Meléndez-Alafort L; Ferro-Flores G; Reyes-Herrera L; Sepúlveda-Méndez J; Sandoval-Guzmán B; Hoyo-Vadillo C
Arch Med Res; 1999; 30(1):49-54. PubMed ID: 10071425
[TBL] [Abstract][Full Text] [Related]
39. Quantification of renal function with a count-based gamma camera method using technetium-99m-MAG3 in children.
Itoh K; Nonomura K; Yamashita T; Kanegae K; Murakumo M; Koyanagi T; Furudate M
J Nucl Med; 1996 Jan; 37(1):71-5. PubMed ID: 8544005
[TBL] [Abstract][Full Text] [Related]
40. Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy.
Melis M; de Swart J; de Visser M; Berndsen SC; Koelewijn S; Valkema R; Boerman OC; Krenning EP; de Jong M
J Nucl Med; 2010 Dec; 51(12):1962-8. PubMed ID: 21078795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
